
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-01-06-2016
- Volume 12
- Issue 1
GENEWIZ Acquires Beckman Coulter Gene Services
GENEWIZ signs definitive agreement to acquire Beckman Coulter's gene services business.
Genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter (GS), according to a Dec. 21, 2015 announcement.
GENEWIZ provides Sanger DNA sequencing, gene synthesis, next generation sequencing, molecular biology bioinformatics, and GLP/GLIA regulatory services. The gene sequencing division of Beckman Coulter provides Sanger and next generation gene sequencing services, with bioinformatics services.
This acquisition will support GENEWIZ’s global expansion strategy by leveraging GS’s 25-plus years of genomics capabilities. It will also aid the company’s international expansion by adding additional locations in the US, UK, China, and Japan.
The agreement was approved by the boards of directors of both companies and closed immediately.
Source:
Articles in this issue
almost 10 years ago
CMO Consolidation Pace May Slow Downalmost 10 years ago
Branded and Generic APIs Look to Strong 2016almost 10 years ago
Sun Pharmaceutical Issued Warning Letter for Microbial Violationsalmost 10 years ago
Collaboration Seeks to Reduce Animal Testingalmost 10 years ago
Recipharm Signs Agreement to Manufacture Liproca Depotalmost 10 years ago
AMRI Acquires Whitehouse Laboratoriesalmost 10 years ago
Quotient Clinical Acquires Co-Formulate Limitedalmost 10 years ago
Capsugel to Acquire Xcelience and Powdersizealmost 10 years ago
FDA Warns of Potential Baclofen API Contaminationalmost 10 years ago
Althea Expands Biological Drug Product Manufacturing OperationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





